Biogen Inc - Nilai perusahaan marang pendapatan BIIB

Logo perusahaan publik biogen.com (BIIB)

Biogen Inc. (BIIB) maintains growth supported by stable cash flows from Alzheimer's drug sales, as evidenced by the EV/Sales multiple. High pricing power for unique SMA medications and patent protection against generics establish a solid profit base. The value 4347.21 represents the current metric, capturing the market valuation of the business relative to revenue, excluding debt.

BIIB Biogen Idec: Multiplikator EV/Sales ing interval 23.11.2025 - 20.11.2026

Biogen Idec - rincian analitis lan metrik utama (BIIB)

- rega saham lan konsensus proyeksi valuasi:
Pambiji fundamental perusahaan:biogen.com - BIIB
Produk asli Biogen Corp

The EV/Sales metric determines the business value, including net debt, per unit of revenue, allowing for an assessment of the asset's real price regardless of financial leverage. Analyzing the lower bound of the range based on current EV/Sales price action helps investors avoid a "value trap" when seeking an entry point. For Biogen Inc. (BIIB), this indicator reflects the market premium for owning a unique therapeutic ecosystem in the field of neurology.

Analisis pesaing

NBIX (Neurocrine Biosciences) - Rasio nilai perusahaan marang pendapatan|RGC: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Axsome (AXSM)|Rasio nilai perusahaan marang pendapatan ACADIA Pharmaceuticals Inc|Nilai perusahaan marang pendapatan Xenon Pharmaceuticals Inc (XENE)|Multiplikator EV/Sales VKTX|Multiplikator EV/Sales supernus.com (SUPN)|Rasio nilai perusahaan marang pendapatan Catalyst Pharmaceuticals, Inc. CPRX|DNLI (Denali Therapeutics Inc.) - Nilai perusahaan marang volume dodolan|Harmony Corp - Multiplikator EV/Sales|BHVN: Rasio nilai perusahaan marang pendapatan|AMLX: Multiplikator EV/Sales|TRVI: Koefisien nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Praxis Medicines|Multiplikator nilai perusahaan marang pendapatan Anavex AVXL|Rasio nilai perusahaan marang pendapatan CeriBell Corp (CBLL)|Koefisien nilai perusahaan marang pendapatan PRTA|Multiplikator EV/Sales ALEC (Alector)|Annexon (ANNX) - Multiplikator nilai perusahaan marang pendapatan|OMER - Rasio nilai perusahaan marang pendapatan|NGNE (Neurogene) - Rasio nilai perusahaan marang pendapatan|ACIU: Multiplikator EV/Sales|VYGR - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Neumora Therapeutics, Inc.|Rasio nilai perusahaan marang pendapatan SCLX (Scilex)|Nilai perusahaan marang pendapatan TVGN (Tevogen Bio)|Multiplikator EV/Sales Alpha Cognition Inc (ACOG)|Multiplikator EV/Sales CGTX (cogrx.com)|Rasio total nilai perusahaan marang pendapatan Inhibikase Pharma (IKT)|SAVA: Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan Assertio ASRT|COYA (coyatherapeutics.com) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan VTGN|OVID (Ovid Therapeutics) - Multiplikator EV/Sales|Acumen Pharmaceuticals, Inc (ABOS) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan CervoMed, Inc. (CRVO)|ATHE - Multiplikator nilai perusahaan marang pendapatan|Multiplikator EV/Sales CLNN (Clene Inc.)|Rasio total nilai perusahaan marang pendapatan PepGen Inc. (PEPG)|JUNS - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Relmada Corp|ANVS (Annovis Bio, Inc.) - Nilai perusahaan marang pendapatan|Grace Tx (GRCE) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan AIFF|Multiplikator EV/Sales anewmeds.com|Rasio nilai perusahaan marang pendapatan NeuroSense Therapeutics (NRSN)|RVPH (Reviva Pharmaceuticals Holdings) - Nilai bisnis marang pendapatan|MetaVia - Nilai perusahaan marang pendapatan|NRXS: Rasio nilai perusahaan marang pendapatan|Helius Medical Technologies, Inc. - Multiplikator EV/Sales|PASG: Rasio nilai perusahaan marang pendapatan|Neuphoria (NEUP) - Rasio nilai perusahaan marang pendapatan|Minerva Neurosciences - Nilai bisnis marang pendapatan|ATHA (Athira Pharma, Inc.) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan addextherapeutics.com ADXN|Nilai perusahaan marang pendapatan ALZN (Alzamend Neuro Inc.)|CYCN (Cyclerion Therapeutics, Inc.) - Nilai bisnis marang pendapatan|Multiplikator EV/Sales PTIX (Protagenic)|Multiplikator EV/Sales pasitheaclinics.com KTTA|CRGT - Rasio nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan ATXI (Avenue Therapeutics)|BCLI: Multiplikator EV/Sales|Cara Therapeutics - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Chromocell Therapeutics Corporation|Multiplikator EV/Sales Eliem Therapeutics Inc.|Rasio nilai perusahaan marang pendapatan Intra-Cellular Therapies, Inc. (ITCI)|LBPH (Longboard Pharmaceuticals) - Nilai bisnis marang pendapatan|Multiplikator EV/Sales MRNS (marinuspharma.com)|NKGN: Rasio nilai perusahaan marang pendapatan|NRBO - Rasio nilai perusahaan marang pendapatan|SAGE - Multiplikator EV/Sales|Synaptogenix (SNPX) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Trevena (TRVN)|Nilai perusahaan marang pendapatan VIGL|Rasio nilai perusahaan marang pendapatan WENA (Anew Medical)|Multiplikator EV/Sales CERE